What does CUSIP 230031106 represent in this 13F holders report?

CUSIP 230031106 is the security identifier for CGEM - Cullinan Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CGEM - Cullinan Therapeutics, Inc. - Common Stock in Q2 2021?

70 institutional investors reported CGEM - Cullinan Therapeutics, Inc. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

Cullinan Therapeutics, Inc. - Common Stock (CGEM)

CUSIP: 230031106

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 59,091,689
Total 13F shares: 32,250,659
Share change: +913,316
Total reported value: $828,539,736
Price per share: $25.75
Number of holders: 70
Value change: -$17,650,444
Number of buys: 38
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 230031106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CGEM - Cullinan Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MPM BioImpact LLC	13F	Company	13%	7,913,887	$329,772,000	—	31 Mar 2021	13F
Foresite Capital Management V, LLC	13F	Company	4.6%	2,731,410	$113,818,000	—	31 Mar 2021	13F
CHI Advisors LLC	13F	Company	3.7%	2,202,407	$91,774,000	—	31 Mar 2021	13F
BAUPOST GROUP LLC/MA	13F	Company	3.1%	1,835,560	$71,699,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	2.1%	1,220,174	$50,845,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.1%	1,212,555	$49,025,000	—	31 Mar 2021	13F
VR Adviser, LLC	13F	Company	2%	1,176,145	$49,010,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.9%	1,151,287	$47,974,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.9%	1,146,145	$47,760,000	—	31 Mar 2021	13F
Rock Springs Capital Management LP	13F	Company	1.8%	1,075,912	$44,833,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	1.8%	1,074,082	$44,757,000	—	31 Mar 2021	13F
BVF INC/IL	13F	Company	1.8%	1,049,356	$43,727,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	1.5%	887,808	$36,995,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	723,584	$30,152,000	—	31 Mar 2021	13F
Avidity Partners Management LP	13F	Company	1.2%	707,359	$29,476,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.92%	542,912	$22,623,000	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.83%	488,308	$20,348,000	—	31 Mar 2021	13F
Logos Global Management LP	13F	Company	0.7%	413,458	$17,229,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.68%	403,836	$16,828,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.59%	350,000	$14,585,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.58%	341,731	$14,240,000	—	31 Mar 2021	13F
Vivo Capital, LLC	13F	Company	0.42%	250,000	$10,418,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	220,267	$9,178,000	—	31 Mar 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.37%	216,630	$9,027,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.33%	194,815	$8,118,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.29%	173,471	$7,229,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.26%	154,539	$6,440,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	0.25%	150,000	$6,250,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.24%	141,240	$5,885,000	—	31 Mar 2021	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.21%	125,000	$5,209,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.19%	111,322	$4,639,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	0.17%	100,000	$4,167,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.15%	86,431	$3,602,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.11%	64,033	$2,668,000	—	31 Mar 2021	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.11%	64,000	$2,667,000	—	31 Mar 2021	13F
Birchview Capital, LP	13F	Company	0.1%	60,114	$2,505,000	—	31 Mar 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.1%	60,000	$2,500,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.09%	56,060	$2,336,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.08%	49,736	$2,073,000	—	31 Mar 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.08%	48,373	$2,017,000	—	31 Mar 2021	13F
J. Goldman & Co LP	13F	Company	0.07%	42,539	$1,773,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	38,201	$1,592,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.06%	34,825	$1,451,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	34,670	$1,445,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.04%	25,000	$1,042,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	23,335	$972,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	0.04%	21,000	$875,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	19,797	$825,000	—	31 Mar 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	18,739	$781,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	11,584	$483,000	—	31 Mar 2021	13F

Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock (CGEM) as of Q2 2021

As of 30 Jun 2021, Cullinan Therapeutics, Inc. - Common Stock (CGEM) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,250,659 shares. The largest 10 holders included MPM Oncology Impact Management LP, Foresite Capital Management V, LLC, CHI Advisors LLC, FMR LLC, BAUPOST GROUP LLC/MA, EVENTIDE ASSET MANAGEMENT, LLC, AMERICAN INTERNATIONAL GROUP, INC., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Rock Springs Capital Management LP. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.